ECM Technologies, a leader in HVAC efficiency and energy conservation, has named Andrew Soulier as its first chief sustainability officer (CSO). In this role, Soulier will oversee all aspects of sustainability for the business, including strategic leadership, market development and stakeholder engagement. He is also responsible for embedding environmental stewardship and leading practice in all aspects of manufacturing, operations and distribution.
Before joining ECM Technologies, Soulier was the founder and CEO of Net Positive Advisors, a sustainability consulting and strategy firm in Phoenix. Prior to that, he spent over a decade with Ernst & Young LLP (EY), driving energy, sustainability and green building projects in a variety of industry sectors around the world. His extensive track record and knack for simplifying complex problems has made him a trusted advisor to many Fortune 500 companies, private equity investors, professional services firms and state/local governments in the United States and abroad.
“We could not be more thrilled to welcome Andrew to our leadership team. Bringing in a trailblazer of his caliber will help us compound our sustainability efforts and further position ThermaClear® as a leading solution to cost-effectively reduce energy and emissions,” said David Fenton, chief revenue officer for ECM Technologies. “Andrew’s expertise and credibility will help forge innovative partnerships, drive sustainable initiatives and set new benchmarks for environmental responsibility within the industry. Most of all, he really knows how to validate the business case for sustainability.”
A resident of Phoenix, Soulier received a bachelor’s degree in mechanical engineering from Arizona State University. He is a LEED-Accredited Professional (LEED-AP®), Certified Energy Manager® and a former IRS Enrolled Agent. Outside of work, Soulier volunteers his time to the U.S. Green Building Council (USGBC), where he sits on the Market Leadership Advisory Board and frequently mentors young professionals. He’s also an ambassador for the Translational Genomics Research Institute (TGen), an Ariz. non-profit focused on cutting edge immunotherapies and specialized medicines.
